IL15 and glioblastoma: NKG2D-CAR-engineered NKAR-NK-92 and NKAR_RD-IL15-NK-92 cells both displayed effective NKAB-EGFR- and NKAB-ErbB2-mediated cytotoxicity against glioblastoma cells.